Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Income Common Stock | Net Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -49.38M | -458.6% | $ 10.77M |
3/31/2025 | $ -50.77M | -254.28% | $ 19.96M |
12/31/2024 | $ -60.48M | -308.05% | $ 19.63M |
9/30/2024 | $ -63.8M | -314.78% | $ 20.27M |
6/30/2024 | $ -72.5M | -350.08% | $ 20.71M |
3/31/2024 | $ -81.22M | -538.81% | $ 15.07M |
12/31/2023 | $ -86.88M | -582.34% | $ 14.92M |
9/30/2023 | $ -73.5M | -691.39% | $ 10.63M |
6/30/2023 | $ -31.65M | -67.62% | $ 46.8M |
3/31/2023 | $ -43.73M | -101.14% | $ 43.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Revenues
(=) Net %
Net % for CARISMA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -48.1M ] / Revenues [ $ 11.24M ]
(=) Net % [ -428.07% ]
Minimum
Mar 31, 2021
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.2K |
---|---|
min | -64.23% |
max | 69.74% |
average | 4.77% |
median | 5.25% |
std | 19.84% |